Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma

Bibliography

• Neugut AI, Jacobson JS, Suh S, The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomark Prev 1998;7:243-51
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Wayne JD, Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009;249:63-71
   PubMed Web of Science ®Google Scholar
• Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg 1984;147:66-71
   PubMed Web of Science ®Google Scholar
• Ross RK, Hartnett NM, Bernstein L, Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer 1991;63:143-5
   PubMed Web of Science ®Google Scholar
• Chow JS, Chen CC, Ahsan H, A population-based study of the incidence of malignant small bowel tumours: SEER, 1973 – 1990. Int J Epidemiol 1996;25:722-8
   PubMed Web of Science ®Google Scholar
• Howe JR, Karnell LH, Menck HR, The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985 – 1995. Cancer 1999;86:2693-706
   PubMed Web of Science ®Google Scholar
• Dabaja BS, Suki D, Pro B, Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-26
   PubMed Web of Science ®Google Scholar
• Schatzkin A, Park Y, Leitzmann MF, Prospective study of dietary fiber, whole grain foods, and small intestinal cancer. Gastroenterology 2008;135:1163-7
   PubMed Web of Science ®Google Scholar
• Chow WH, Linet MS, McLaughlin JK, Risk factors for small intestine cancer. Cancer Causes Control 1993;4:163-9
   PubMed Web of Science ®Google Scholar
• Negri E, Bosetti C, La Vecchia C, Risk factors for adenocarcinoma of the small intestine. Int J Cancer 1999;82:171-4
   PubMed Web of Science ®Google Scholar
• Delaunoit T, Neczyporenko F, Limburg PJ, Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Am J Gastroenterol 2005;100:703-10
   PubMed Web of Science ®Google Scholar
• Sellner F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 1990;66:702-15
   PubMed Web of Science ®Google Scholar
• Zollinger RM. Primary neoplasms of the small intestine. Am J Surg 1986;151:654-8
   PubMedGoogle Scholar
• Maglinte DD, O'Connor K, Bessette J, The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 1991;86:304-8
   PubMedGoogle Scholar
• Marmo R, Rotondano G, Piscopo R, Meta-analysis: capsule enteroscopy vs. conventional modalities in diagnosis of small bowel diseases. Aliment Pharmacol Ther 2005;22:595-604
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Harstrick A, Rustum YM. Modulation of fluoropyrimidines: role of dose and schedule of leucovorin administration. Semin Oncol 1992;19(2 Suppl 3):10-5
   PubMed Web of Science ®Google Scholar
• Miwa M, Ura M, Nishida M, Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998;34:1274-81
   PubMed Web of Science ®Google Scholar
• Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005;352:476-87
   PubMed Web of Science ®Google Scholar
• Abou El Fadl MH, Bagai RK, Spiro TP, 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel. Gastrointest Cancer Res 2009;3:167-70
   PubMedGoogle Scholar
• Posner JB. Side effects of chemotherapy. In: Posner JB, editor. Neurologic complications of cancer. FA Davis, Philadelphia, PA; 1995. p. 299-300
   Google Scholar
• Furuta T. Pharmacogenomics in chemotherapy for GI tract cancer. J Gastroenterol 2009;44:1016-25
   PubMed Web of Science ®Google Scholar
• Rochlin DB, Smart CR, Silva A. Chemotherapy of malignancies of the gastrointestinal tract. Am J Surg 1965;109:43-6
   PubMed Web of Science ®Google Scholar
• Morgan DF, Busuttil RW. Primary adenocarcinoma of the small intestine. Am J Surg 1977;134:331-3
   PubMed Web of Science ®Google Scholar
• Moon YW, Rha SY, Shin SJ, Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators. J Cancer Res Clin Oncol 2009. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19760196 [Last accessed 27 December 2009]
   Google Scholar
• Zouhairi ME, Venner A, Charabaty A, Small bowel adenocarcinoma. Curr Treat Options Oncol 2008;9:388-99
   PubMed Web of Science ®Google Scholar
• Overman MJ, Kopetz S, Wen S, Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer 2008;113:2038-45
   PubMed Web of Science ®Google Scholar
• Suenaga M, Mizunuma N, Chin K, Chemotherapy for small-bowel adenocarcinoma at a single institution. Surg Today 2009;39:27-31
   PubMed Web of Science ®Google Scholar
• Fishman PN, Pond GR, Moore MJ, Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 2006;29:225-31
   PubMed Web of Science ®Google Scholar
• Overman MJ, Varadhachary GR, Kopetz S, Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol 2009;27:2598-603
   PubMed Web of Science ®Google Scholar
• Aparicio T, Costes L, Moulin V, Efficacy of recent chemotherapy regimen in advanced small bowel carcinoma. J Clin Oncol 2007;25(18 Suppl):15112
   Google Scholar
• Gibson MK, Holcroft CA, Kvols LK, Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist 2005;10:132-7
   PubMed Web of Science ®Google Scholar
• Copson ER, Darby A, Harvey M, Epirubicin, Cisplatin and infusional 5-fluorouracil chemotherapy for locally advanced and metastatic small bowel adenocarcinoma. Proc Am Soc Clin Oncol 2002;21:2347
   Google Scholar
• Crawley C, Ross P, Norman A, The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 1998;78:508-10
   PubMed Web of Science ®Google Scholar
• Bahulikar AV, Joshi JN. Laryngopharyngeal dysthesia (LPD) in oxaliplatin infusion (OXLP). J Assoc Physicians India 2006;54:667
   PubMedGoogle Scholar
• Raymond E, Faivre S, Chaney S, Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 2002;1:227-35
   PubMed Web of Science ®Google Scholar
• Hsiang YH, Hertzberg R, Hecht S, Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985;260:14873-8
   PubMed Web of Science ®Google Scholar
• Klein CE, Gupta E, Reid JM, Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide. Clin Pharmacol Ther 2002;72:638-47
   PubMedGoogle Scholar
• Polyzos A, Kouraklis G, Giannopoulos A, Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 2003;15:503-6
   PubMed Web of Science ®Google Scholar
• Cao J, Zuo Y, Lv F, Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients. J Clin Gastroenterol 2008;42:167-73
   PubMed Web of Science ®Google Scholar
• Overman MJ. Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res 2009;3:90-6
   PubMedGoogle Scholar
• Hong SH, Koh YH, Rho SY, Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol 2009;39:54-61
   PubMed Web of Science ®Google Scholar
• Halfdanarson TR, Quevedo F, McWilliams RR. Small bowel adenocarcinoma: a review of 491 cases. J Clin Oncol 2006;24(18 Suppl):4127
   Google Scholar
• Locher C, Malka D, Boige V, Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290-4
   PubMed Web of Science ®Google Scholar
• Czaykowski P, Hui D. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency. Clin Oncol (R Coll Radiol) 2007;19:143-9
   PubMed Web of Science ®Google Scholar
• Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 1984;53:23-5
   PubMed Web of Science ®Google Scholar
• Ono M, Shirao K, Takashima A, Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine. Gastric Cancer 2008;11:201-5
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Earl C, Zhu A, Phase I dose finding and pharmacologic study of cisplatin, irinotecan, and either capecitabine or infusional 5-FU in patients with advanced gastrointestinal malignancies [abstract 28]. Presented at the ASCO 2005 Gastrointestinal Cancers Symposium, 27 – 29 January 2005; Miami, Florida, USA
   Google Scholar